Fluicell AB Logo

Fluicell AB

Developing bioprinted tissues for regenerative medicine and advanced drug screening.

FLUI | ST

Overview

Corporate Details

ISIN(s):
SE0010831321 (+1 more)
LEI:
549300R9LVFVFDTW5Y96
Country:
Sweden
Address:
Flöjelbergsgatan 8c, 431 37 Mölndal
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Fluicell AB is a biotechnology company specializing in single-cell biology and high-precision tissue engineering. The company develops solutions for regenerative medicine and drug screening through its groundbreaking Nexocyte™ platform, which is based on its patented, high-resolution Biopixlar™ single-cell bioprinting technology. Fluicell's primary focus is creating precision-engineered, transplantable tissues to treat diseases with significant unmet needs, with an initial goal to develop a cure for type 1 diabetes. In parallel, the Nexocyte platform generates advanced tissue models for pharmaceutical partners to enhance drug screening, particularly for cardiac and kidney toxicity. The company also commercializes a portfolio of research tools, including the BioPen® and Dynaflow® systems, that support single-cell research globally.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Fluicell AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Fluicell AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
HVIVO PLC Logo
A CRO running human challenge trials to test infectious disease vaccines for pharma/biotech clients.
United Kingdom HVO
Iconovo AB Logo
Develops inhaled therapies and patented dry powder inhalers for global pharma partners.
Sweden ICO
IMMUPHARMA PLC Logo
Develops novel peptide therapeutics for autoimmune diseases like Lupus (SLE) and CIDP.
United Kingdom IMM
Inhalation Sciences Sweden AB Logo
Inhalation research instruments and CRO services for preclinical pharma/biotech development.
Sweden ISAB
Initiator Pharma A/S Logo
Clinical-stage firm developing drugs for nervous system disorders like ED & trigeminal neuralgia.
Denmark INIT
IXICO PLC Logo
AI-powered neuroimaging and biomarker analytics for neurological clinical trials.
United Kingdom IXI
J. Molner AS Logo
A CDRO specializing in generic injectable and topical drugs for the North American market.
Estonia JML
LYSOGENE Logo France LYS
Mazaro N.V. Logo
Engineering patented, high-efficiency transmissions for vehicles and industrial drivelines.
Belgium MLMAZ
Medivir Logo
Clinical-stage pharma firm developing tumor-directed therapies for high-need cancer patients.
Sweden MVIR

Talk to a Data Expert

Have a question? We'll get back to you promptly.